08.04.2010 • NewsAkzoNobelMCAmonochloroacetic acid

Akzo Nobel expanding capacity in China

Akzo Nobel has announced the completion its plant expansion for the manufacture of monochloroacetic acid (MCA) in China.

The company's Taixing site - which now boasts production capacity of 60,000 MT/year - is the largest of its kind in China. It will help to meet steadily increasing demand for MCA in China, where the market is growing in line with GDP at more than 10% annually. MCA is a chemical intermediate which is widely used for the production of agrochemicals, carboxymethylcellulose (CMC), surfactants and a variety of other applications.

The Taixing plant - which now has more than double the original design capacity - incorporates state-of-the-art proprietary technologies and best-in-class HSE standards to deliver a superior cost position coupled with the lowest environmental footprint available in the market.

It represents the latest in a series of key developments for Akzo Nobel in China. Last year, the company inaugurated a Powder Coatings Technology Center in Ningbo, while in December, the new chelates facility located at the €275 million Ningbo multi-site became operational. The Ningbo site is due to be officially opened in November.

AkzoNobel employs more than 6,000 people in China and generates more than €1 billion annually in revenue.

Company

Logo:

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.